Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2016 Mar 1;11(3):e0150233. doi: 10.1371/journal.pone.0150233. eCollection 2016.

Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies.

Author information

1
Department of Internal Medicine and Internal Medicine in Nursing, Medical University, Lublin, Poland.
2
Department of Endocrinology, Medical University, Lublin, Poland.
3
Department of Virology and Immunology, Maria Curie-Skłodowska University, Lublin, Poland.
4
Department of Gastroenterology with the Endoscopic Laboratory, Medical University, Lublin, Poland.

Abstract

BACKGROUND:

Toll-like receptor 4 (TLR4) contributes to the development of NAFLD (nonalcoholic fatty liver disease) and MetS (metabolic syndrome). It is unclear whether anti-diabetic metformin affects TLR4 expression on blood monocytes, thereby protecting or improving inflammatory parameters. Therefore, we investigated TLR4 in patients with NAFLD meeting different sets of MetS criteria and linked the results with the disease burden.

METHODS:

70 subjects were characterized and divided into three groups: (I) healthy individuals, (II) nonobese with NAFLD and without MetS, and (III) prediabetic, obese with NAFLD and MetS. We determined the concentrations of IL-1β, IL-6, TNFα, and monocyte TLR4 levels in fresh blood as well as in blood cultures with or without metformin supplementation.

RESULTS:

The characteristics of the study groups revealed a significant association between NAFLD and BMI, MetS and inflammatory parameters, and TLR4. In ex vivo studies, 100 μM of metformin decreased the TLR4 level by 19.9% (II group) or by 35% (III group) as well as IL-1β and TNFα production. A stepwise multiple regression analysis highlighted a strong effect of metformin on attenuation of the link between TLR4 and NAFLD, and TNFα.

CONCLUSION:

We concluded that, by attenuation of the blood monocyte TLR4 level, metformin reduced their inflammatory potential-critical after recruitment these cells into liver. However, this finding should be confirmed after in vivo metformin administration.

PMID:
26930651
PMCID:
PMC4773077
DOI:
10.1371/journal.pone.0150233
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center